Saga University · Medical Sciences

Research keywordschronic myeloid leukemia・tyrosine kinase inhibitors・T-cell repertoire・double-hit lymphoma・epcoritamab・generic imatinib

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Clinical Features and T-Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC-TFR Study.2025 · Cancer medicine
• Orally available decitabine prodrug OR-2100 induces mitotic perturbation for the treatment of double-hit lymphoma2025 · Blood Neoplasia
• Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration data.2025 · Cancer chemotherapy and pharmacology
• Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine.2025 · Cancer science

• Official profile